Alzheimer. Other degenerative disorders of nervous system in diseases classified elsewhere
Conditions
Interventions
Intervention 1: The control group is only used common drug (galantamine pill, rivastigmine capsule or danepzil tablet) for 12 weeks. Intervention 2: Intervention group was received Vaj syrup half an h
Treatment - Drugs
The control group is only used common drug (galantamine pill, rivastigmine capsule or danepzil tablet) for 12 weeks.
Intervention group was received Vaj syrup half an hour before each meal, each time they received 10 mg with the common medicine.
Sponsors
Traditional Medicine and History Research Center of Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
46 Years to 16 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged over 50 years? CDR score less than or equal to 2? ADAS-COG score greater than or equal to 12? no heart disease? no high blood pressure? no drug abuse and alcohol dependency?Non use of anticoagulants? no diabetes -ability to participate in the study? no more than 80 years old? definite Alzheimer's disease Outcome criteria : bipolar disorder ??? mild to severe depression ? co-morbidity with other neurological diseases ? inability to participate in the study? Inability to continue treatment ? causing side effects
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Alzheimer. Timepoint: four, eight, twelve weeks after intervention. Method of measurement: CDR and ADAS-COG questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: four, eight, twelve weeks after intervention. Method of measurement: Self-made questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadese Kamali
Kerman University of Medical Sciences, School of Persian Medicine
Outcome results
None listed